Clinton Group’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-5,324
| Closed | -$2M | – | 475 |
|
|
2017
Q4 | $2M | Buy |
+5,324
| New | +$2M | 0.18% | 178 |
|
|
2016
Q4 | – | Sell |
-16,499
| Closed | -$6.63M | – | 967 |
|
|
2016
Q3 | $6.63M | Buy |
16,499
+13,733
| +496% | +$5.52M | 0.31% | 86 |
|
|
2016
Q2 | $966K | Sell |
2,766
-5,263
| -66% | -$1.84M | 0.04% | 491 |
|
|
2016
Q1 | $2.89M | Buy |
8,029
+5,220
| +186% | +$1.88M | 0.17% | 174 |
|
|
2015
Q4 | $1.53M | Buy |
2,809
+2,304
| +456% | +$1.25M | 0.12% | 260 |
|
|
2015
Q3 | $235K | Buy |
+505
| New | +$235K | 0.02% | 595 |
|
|
2015
Q2 | – | Sell |
-2,051
| Closed | -$926K | – | 680 |
|
|
2015
Q1 | $926K | Buy |
+2,051
| New | +$926K | 0.24% | 120 |
|
|
2014
Q2 | – | Sell |
-722
| Closed | -$217K | – | 406 |
|
|
2014
Q1 | $217K | Sell |
722
-490
| -40% | -$147K | 0.08% | 307 |
|
|
2013
Q4 | $334K | Sell |
1,212
-355
| -23% | -$97.8K | 0.11% | 219 |
|
|
2013
Q3 | $490K | Buy |
+1,567
| New | +$490K | 0.15% | 187 |
|